Rinitis alérgica

  1. Antolín Amérigo Soto, D.
  2. Sánchez González, M.J.
  3. Barbarroja Escudero, J.
  4. Álvarez-Mon, M.
Journal:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Year of publication: 2017

Series: 12

Issue: 30

Pages: 1757-1766

Type: Article

DOI: 10.1016/J.MED.2017.03.011 DIALNET GOOGLE SCHOLAR

More publications in: Medicine: Programa de Formación Médica Continuada Acreditado

Abstract

Abstract Concept Rhinitis is defined as nasal conditions characterised by sneezing, nasal itching, rhinorrhoea and nasal obstruction or congestion, which makes it a risk factor for potential respiratory complications. Epidemiology It is an underestimated cause for morbidity, originating high costs for those who suffer from it, both economic and social ones, affecting their quality of life. AR is the most frequent allergic disease and one of the most frequent conditions worldwide, particularly in developed countries. Classification It is classified as allergic rhinitis (AR) or nonallergic rhinitis, and they are subdivided according to their frequency into persistent (more than 4 days a week and more than 4 consecutive weeks) or intermittent (does not meet previous criteria), and according to their severity into moderate-severe (if it affects sleep, daily routine or of symptoms are unpleasant) or mild (if it does not meet the criteria for moderate-severe). Diagnosis Diagnosis is reached by analysing medical records, conducting skin and/or specific IgE tests, as well as other useful complementary tests. Treatment Many patients remain untreated, undertreated or treated incorrectly. Starting an adequate treatment for patients with AR would make significant savings in indirect costs.

Bibliographic References

  • T. Dordal Culla, F. Vega de la Osada, V. González Núñez, M.L. González Gutiérrez. Rinitis alérgica. Capítulo 8 I. Dávila, I. Jáuregui, J. Olaguibel, J. Zubeldía (Eds.), Tratado de alergología SEAIC (2ª ed.), Ergón, Madrid (2016), pp. 489-511
  • V. Bauchau, S.R. Durham. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J., 24 (2004), pp. 758-64
  • E. Tornador Gaya, R. Tosca Segura, A. Arnedo Pena, J. Puig Barbera, J.B. Bellido Blasco, M.R. Pac Sa. Incidence of allergic rhinitis in a cohort of schoolchildren between 1994 and 2002 in Castellon (Spain), following the ISAAC study. An Pediatr (Barc)., 66 (2007), pp. 154-8
  • B. de la Hoz Caballer, M. Rodríguez, J. Fraj, I. Cerecedo, D. Antolín Amérigo, C. Colás. Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross sectional study to evaluate work Productivity in allergic Rhinitis compared with other common diseases (CAPRI) study. Am J Rhinol Allergy., 26 (5) (2012), pp. 390-4
  • A. Togias. Mechanistic features of allergic rhinitis. J Allergy Clin Immunol., 105 (2000), S559-604
  • C. Pereira, A. Valero, C. Loureiro, I. Davila, Martínez Cocera, C. Murio. Iberian study of aeroallergens sensitisation in allergic rhinitis. Allerg Immunol., 38 (2006), pp. 186-94
  • A. Navarro, A. Valero, B. Juliá, S. Quirce. Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study. J Investig Allergol Clin Immunol., 18 (4) (2008), pp. 233-8
  • J.A. Castillo Vizuete, J. Mullol Miret. Rhinitis and asthma comorbidity in Spain: the RINAIR study. Arch Bronconeumol., 44 (11) (2008), pp. 597-603
  • R.A. Nathan. Management of patients with allergic rhinitis and asthma: literature review. South Med J., 102 (9) (2009), pp. 935-41
  • G. Scadding. Cytokine profiles in allergic rhinitis. Curr Allergy Asthma Rep., 14 (5) (May 2014), p. 435
  • J. Bousquet, H.J. Schunemann, J. Fonseca, B. Samolinski, C. Bachert, G.W. Canonica. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. Allergy., 70 (11) (2015), pp. 1372-92
  • E. Macy. A rhinitis primer for family medicine. Perm J, 16 (4) (2012), pp. 61-6
  • P.S. Norman. A rational approach to desensitization. J Allergy., 44 (1969), pp. 129-45
  • J.T. Connell. Quantitative intranasal pollen challenges, 3: the priming effect in allergic rhinitis. J Allergy., 43 (1969), pp. 33-44
  • J. Bousquet, W. Jacquot, A. Vignola, C. Bachert, P. van Cauwenberge. Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol., 113 (2004), pp. 43-9
  • P. Small, H. Kim. Allergic rhinitis. Allergy Asthma Clin Immunol., 7Suppl1 (2011), p. S3
  • N. Lakhani, M. North, A.K. Ellis. Clinical manifestations of allergic rhinitis. J Allergy Therapy., S5 (2012), pp. 007
  • H.A. Kakli, T.D. Riley. Allergic Rhinitis. Prim Care, 43 (3) (2016), pp. 465-75
  • T. Haahtela, G.J. Burbach, C. Bachert, C. Bindslev Jensen, S. Bonini, J. Bousquet. Clinical relevance is associated with allergen specific wheal size in skin prick testing. Clin Exp Allergy., 44 (3) (2014), pp. 407-16
  • M.T. Dordal, M. Lluch Bernal, M.C. Sánchez, C. Rondón, A. Navarro, J. Montoro. SEAIC Rhinoconjunctivitis Committee Allergen Specific Nasal Provocation Testing: Review by the Rhinoconjunctivitis Committee of the Spanish Society of Allergy and Clinical Immunology. J Investig Allergol Clin Immunol., 21 (2011), pp. 1-12
  • M. Okano, T. Fujiwara, T. Higaki, S. Makihara, T. Haruna, Y. Noda. Characterization of pollen antigen-induced IL-31 production by PBMCs in patients with allergic rhinitis. J Allergy Clin Immunol., 127 (1) (2011), pp. 277-9, 279.e1-11
  • G. Ottaviano, W.J. Fokkens. Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practice. Allergy., 71 (2) (2016), pp. 162-74
  • V. Hox, S. Bobic, I. Callebaux, M. Jorissen, P.W. Hellings. Nasal obstruction and smell impairment in nasal polyp disease: correlation between objective and subjective parameters. Rhinology., 48 (2010), pp. 426-32
  • N.G. Papadopoulos, J.A. Bernstein, P. Demoly, M. Dykewicz, W. Fokkens, P.W. Hellings. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy., 70 (5) (2015), pp. 474-494
  • D.I. Bernstein, G. Schwartz, J.A. Bernstein. Allergic rhinitis: mechanisms and treatment. Immunol Allergy Clin North Am., 36 (2) (2016), pp. 261-78
  • L. Klimek, J. Mullol, P. Hellings, P. Gevaert, R. Mösges, W. Fokkens. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis. Expert Opin Pharmacother., 17 (5) (2016), pp. 657-69
  • L.M. Wheatley, A. Togias. Clinical practice. Allergic rhinitis. N Engl J Med., 372 (5) (2015), pp. 456-63
  • S.R. Durham, W. Emminger, A. Kapp, G. Colombo, J.G. de Monchy, S. Rak. Long term clinical efficacy in grass pollen induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet. J Allergy Clin Immunol., 125 (1) (2010), pp. 131-7
  • C. Moreno Aguilar, M.A. Gonzalo Garijo, I. Sánchez Machín. Seguridad y eficacia de la inmunoterapia. I.J. Dávila González, I. Jáuregui Presa, J.M. Olaguíbel Rivera, J.M. Zubeldia Ortuño (Eds.), Tratado de alergología. (2ª ed.), Ergón-SEAIC, Tomo III. Madrid (2016), pp. 1181-94
  • C. Ozcan, O. Ismi. Botulinum toxin for rhinitis. Curr Allergy Asthma Rep., 16 (8) (2016), p. 58
Data source: Dialnet